our
company

Momentis Surgical™ has set out to transform robotic-assisted surgery, with proprietary technology that has the potential to far surpass today’s best solutions. Providing unprecedented access and maneuverability, our Momentis Surgical’s Anovo™ Surgical System features miniature, humanoid-shaped robotic arms with human dexterity, superhuman flexibility, and 360˚ articulation. In addition to these features, the system will be sold at a significantly lower price compared to other marketed robotic surgery systems potentially allowing more medical facilities including hospitals and ambulatory surgical centers to access and adopt surgical robotics. Beyond the current applications for transvaginal procedures, Momentis Surgical is further developing this technology to explore its use in abdominal single and multi-port surgery, as well as other transluminal indications.

  • Dvir Cohen Chief Executive Officer

    Dvir Cohen has served as Momentis Surgical’s Chief Executive Officer since October 2013. Mr. Cohen has been a leader in Momentis from its inception and brings more than 15 years of experience in innovative robotic systems. Prior to joining Momentis Surgical, Mr. Cohen served in various positions in the Israeli Ministry of Defense as an awarded officer specializing in robotic systems for various applications. From 2011 to 2013, Mr. Cohen held the positions of research and development manager and robotic project specialist in an elite technology unit of the Israel Intelligence Force. From 2007 to 201, Mr. Cohen led several opto-mechanical disruptive solutions in the Ministry of Defense, one of which won the Israel Defense Award. Mr. Cohen has experience at all stages of product development, from the early conceptual stage through prototyping to production line implementation and final marketing of government and defense units. Mr. Cohen’s recent recognitions include receiving the Deal of the Year Award from BioFlorida, a life sciences industry association, for Momentis Surgical’s $96 million Series D financing and being named an Endeavor Entrepreneur by Endeavor Miami, an affiliate of the global Endeavor organization leading the global high-impact entrepreneurship movement. Mr. Cohen earned an MBA from the Recanati Business School at Tel Aviv University, majoring in Business Strategy and Entrepreneurship. He also earned a Bachelor of Science and a Master of Science degree in mechanical engineering from the Technion as part of the “Brakim” excellence program.

    Noam Atar Chief Financial Officer

    Noam Atar has served as our Chief Financial Officer since January 2020. Mr. Atar brings more than 20 years of experience as a finance and operations executive with a strong track record formulating and executing strategic initiatives across business operations and changing management, conceptualizing and leading on multi-functional process and performance transformations, generating consensus through collaboration and organizational alignment, and introducing innovation to achieve financial and business goals. Prior to joining Momentis Surgical, Mr. Atar served as Senior Director of Finance & Supply Chain at Ferring Pharmaceuticals from June 2015 to January 2020 where he led company-wide strategic and operational initiatives. From 2009 to 2015, Mr. Atar served as controller of Bio Technology General Ltd and from 2007 to 2009 as the controller of international operations of Radware, an Israeli Nasdaq-listed company (NASDAQ: RDWR). From 2004 to 2007, Mr. Atar served as a senior auditor at PWC. Mr. Atar was also the co-founder & CEO of Rway Applications. Mr. Atar is a certified public accountant and holds a Bachelor of Accounting and Economics degree from the Hebrew University and an MBA from the Recanati Business School at Tel Aviv University. In addition, Mr. Atar is certified in business analytics by Harvard Business School Online.

    Hagai Berkovich Chief Operations Officer

    Hagai Berkovich has served as our Chief Operations Officer since October 2018. Mr. Berkovich has more than 24 years of executive, leadership and management experience in operations. Before joining Momentis Surgical, Mr. Berkovich served as Supply Chain Director at Check-Cap, a medical device company developing the world’s first ingestible imaging capsule system for colorectal cancer screening. His previous experience includes serving as COO at Motorika, a robotic company for rehabilitation solutions, and as Operations VP and CEO at Tamuz F.T.K Solutions, where he led the scale up activities with respect to the Mazor robotic system. His other roles have included Operations, Airborne Structure Director at Elbit Systems – Cyclone and Business Unit Vice President at Sanmina SCI – Israel Medical Systems. Mr. Berkovich holds an MBA from the Recanati Business School at Tel Aviv University and a Bachelor of Science degree in aeronautical engineering from the Technion.

    Stavit Cohen Senior Vice President, R&D

    Stavit Cohen has served as Momentis Surgical’s Senior Vice President of Research and Development since 2021. Ms. Cohen brings deep experience in leading R&D at a senior leadership level at companies with advanced medical technologies. Ms. Cohen has a proven track record in driving innovation and creating the backbone of a top-notch R&D organization with the use of best-in-class practices and methodologies. Previously, she served as Senior Director of R&D and Site Leader at EPD Solutions, a Philips company where she played key roles in delivering an innovative strategic roadmap, technology adoption, and partnerships with Medtronic, Inc. Before that, Ms. Cohen held various roles at Abbott Laboratories, most recently serving as R&D Leader, Site Leader and Chief Executive Officer of MediGuide, Inc. (acquired by St. Jude Medical, Inc. in 2008, which was subsequently acquired by Abbott in 2017). Ms. Cohen earned an MBA and a Bachelor of Science degree in computer science from Technion - Israel Institute of Technology.

    Dr. Michael Conditt Senior Vice President, Strategic Marketing & Clinical Development

    Dr. Michael Conditt has led product management, clinical development and post-market clinical research at Momentis since 2021. Dr. Conditt has 25 years of experience in innovative medical devices, sensors, robotics, biomechanics, and clinical research at medical device startup companies. Prior to joining Momentis Surgical, Dr. Conditt was VP of Clinical Development at OrthoSensor (acquired by Stryker Corporation in 2021), a company developing and commercializing intelligent orthopedic devices and data services that provide quantitative feedback to surgeons and hospitals. Prior to OrthoSensor, Dr. Conditt established a multi-faceted, comprehensive clinical research program at MAKO Surgical Corp. At MAKO, he worked with key opinion leaders to establish the clinical and economic value of less invasive, more accurate robotic-assisted surgery. Following MAKO’s acquisition by Stryker for $1.7 billion, he helped lead the integration of robotics into Stryker’s portfolio. Dr. Conditt also developed the clinical strategy at Surgical Theater, providing guidance for the application of augmented reality technology for neurosurgery. Dr. Conditt has authored more than 75 peer-reviewed manuscripts and received numerous academic honors and awards for his research. He earned a PhD degree in biomedical engineering from Northwestern University, where he built a haptic robot to study human motor control, a Master of Science degree in bioengineering from the University of Pennsylvania and a Bachelor of Science degree in mechanical engineering from Texas Tech University.

    Thomas Klug Senior Vice President, Customer Services & US Operations

    Thomas Klug has served as Momentis Surgical’s Senior Vice President, Customer Services & US Operations since 2020. Mr. Klug brings more than 30 years of medical device customer service and operations experience to Momentis Surgical. Mr. Klug spent 10 years of his career building customer service organizations at start-up medical device companies. Prior to joining Momentis Surgical, he served as Vice President, Global Customer Care at Synaptive Medical, an innovative Toronto-based company revolutionizing surgical visualization and patient imaging. Before that, he was Vice President of Global Customer Support at MAKO Surgical Corp. where his team supported the rapid growth and success of the start-up orthopedics robotics company that was ultimately acquired by Stryker Corporation for $1.7 billion. With more than 17 years in Carl Zeiss’ medical device division, Mr. Klug had roles of increasing responsibilities and completed his time with them as Director of Field Services where he was responsible for installation, service and maintenance of opto-electronic diagnostic and surgical instrumentation including surgical laser systems. Mr. Klug earned a degree in electronic engineering from Cayuga College and a Certificate in International Business Management from Georgetown University.

    Ariela Levi Senior Vice President, People

    Ariela Levi has been responsible for overseeing Momentis Surgical’s human resource initiatives since 2021. Ms. Levi is a seasoned HR leader with experience in talent acquisition, organization design and development, and HR business partnering. Her areas of expertise also include building a culture of engagement and high performance and steering global organizations through growth and transformation. She is passionate about people, building forward-thinking teams, and providing valuable interactions. Before joining Momentis Surgical, from 2006 to 2021, she served in roles of increasing responsibility at NICE Systems, including serving as Vice President of HR for NICE Actimize from 2018 to 2021. She has a Bachelor of Science degree in psychology and management from Tel Aviv University.

    Chad Zaring Chief Commercial Officer

    Chad Zaring has led Momentis Surgical’s commercialization efforts since 2021. Mr. Zaring has nearly 20 years of industry experience with proven success in driving commercial results at innovative robotic surgery companies including Intuitive Surgical and Mazor Robotics (acquired by Medtronic plc in 2018). In his most recent position as Chief Commercial Officer at Venus Concept Inc., Mr. Zaring was responsible for global sales, marketing and training strategy and robotics R&D. Mr. Zaring previously served as District Manager at Ethicon Endo-Surgery, a subsidiary of Johnson & Johnson, and as a urology sales representative at Merck and Co., Inc. Mr. Zaring earned a Bachelor of Arts degree in biology from Juniata College in Pennsylvania.
  • Maurice Ferré Chairman of the Board

    Dr. Maurice Ferré has served as Chairman of Momentis Surgical’s board of directors since March 2018. Dr. Ferré has also served as CEO and chairman of the board of directors of Insightec Ltd., an innovator in the field of incisionless surgery, since December 2014. In addition, Dr. Ferré has served as chairman of the board of directors of DermaSensor, Inc. since 2011, a director of Heru, Inc. since 2020, a director of MIVI Neuroscience, Inc. since 2018, and a director of MedTech Acquisition Corporation (NASDAQ: MTAC), a publicly traded special acquisition corporation, since December 2020. Dr. Ferré brings over 20 years of experience as an entrepreneur in the medical technology industry. From 2004 to 2014, Dr. Ferré served as CEO and chairman of the board of directors of MAKO Surgical Corp., a transformational robotic surgical company that he co-founded. MAKO was acquired by Stryker Corporation for $1.65 billion in 2013. Prior to MAKO, Dr. Ferré was founder, CEO and President of Visualization Technology Inc. (VTI). VTI became the world leader in image-guided surgery with a navigation platform for ENT and was acquired by GE Healthcare in 2002. Dr. Ferré received his Doctor of Medicine and Master of Public Health from Boston University in 1992. He was the recipient of the prestigious Ernst & Young 2007 Entrepreneur of the Year Award and was awarded BioFlorida’s Lifetime Achievement Award in 2018. Dr. Ferré is also a member of the Board of Trustees for Boston University and active on the boards of The Everglades Foundation and Endeavor Miami.

    Eyal Lifschitz Board Member

    Eyal Lifschitz has served as a Momentis Surgical director since October 2015. Mr. Lifschitz is Co-Founder and a Managing General Partner of Peregrine Ventures, an Israeli life science venture capital fund that focuses on therapeutic devices and medical software. Mr. Lifschitz also serves as a director of several private companies on behalf of Peregrine, including CardioValve, Cordio Medical Ltd., and other private companies. Prior to founding Peregrine Ventures, Mr. Lifschitz co-founded and led the business development efforts of multiple medical technology companies, including PharmaSys (acquired by Elan Corp. NYSE:ELN), ECR Limited (acquired by AVX Corp. NYSE:AVX), Visioncare Ophthalmic Technologies, and BioControl Ltd. From 2003-2007, Mr. Lifschitz also served as a director of Neovas Inc. and Given Imaging Ltd., both publicly listed companies. Mr. Lifschitz chairs the IEI Israel Early-Stage Investors Association, founded and chairs GamVeGam, a non-profit cooperation between the Israeli Ministry of Education and the Israeli high-tech industry which encourages and guides people from the high-tech industry to become teachers in Israeli public schools. Mr. Lifschitz holds a Bachelor of Laws from the Academic College of Law and Sciences.

    Lior Shahory Board Member

    Lior Shahory has served as a Momentis Surgical director since January 2013. Mr. Shahory is a General Partner of Peregrine Ventures, an Israeli life science venture capital fund that focuses on therapeutic devices and medical software. Mr. Shahory also serves as CEO of Incentive, Peregrine’s technology incubator. Under his leadership, Incentive has received seven excellence awards from the State of Israel. Mr. Shahory also serves on the board of directors of several private companies on behalf of Peregrine. Prior to Peregrine, Mr. Shahory served as deputy director of the Israel Chief Scientist’s incubator program. Mr. Shahory holds a BA in economics and business management from the University of Haifa, and an MBA from Tel Aviv University.

    Dr. Irit Yaniv M.D.Board Member

    Dr. Irit Yaniv has served as a Momentis Surgical director since September 2014. Dr. Yaniv is an experienced healthcare technologies investor and executive, with more than 25 years of experience in the venture capital, pharmaceutical and biotech industries. Dr. Yaniv is a Partner at Accelmed, an investment firm focused on medical device companies and technologies, where she plays a key role in leading Accelmed’s early-stage portfolio companies, serving either as chairperson or as an active board member. Dr. Yaniv also currently serves as the CEO and Co-Founder of Almeda Ventures (TASE:AMDA), a public R&D partnership that invests in healthcare technologies. Dr. Yaniv previously served as CEO at medical device companies Impulse Dynamics and MetaCure. Dr. Yaniv holds an MD degree from Ben Gurion University and an MBA from the Recanati Business School at Tel Aviv University.

    Dr. Morry Blumenfeld Board Observer

    Dr. Morry Blumenfeld has served as a Momentis Surgical board observer since February 2016. Dr. Blumenfeld is president and CEO of Quescon Consultants, Ltd., a medical device consulting company, and a partner at Meditech Advisors, LLC. He was an executive at GE for nearly 35 years, and served GE Medical Systems Business in numerous roles, including initiating both the CT and MRI businesses, and as managing director of GE Medical Systems in Israel. Dr. Blumenfeld holds five patents and serves or has served on the boards of a number of medical device and technology companies in the USA and Israel – as well as numerous Canadian, international, and Israeli advisory boards in technology and science. He is on the board of the Hebrew University and Yissum (the Hebrew University’s tech transfer company), and on the scientific advisory board of the Momentum Fund of Ramot (Tel Aviv University’s tech transfer company). Dr. Blumenfeld received his undergraduate degree and Ph.D from the University of Toronto.
back to top
think nimble

think nimble

Anovo™ Surgical System
think boundless

think boundless

clinical spectrum
think forward

think forward

news & events
think together

think together

contact us